carvedilol has been researched along with Vascular Diseases in 4 studies
Vascular Diseases: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Carvedilol inhibited the increase in cell number induced by foetal calf serum (FCS) in 86% (18 of 21) of human VSMC grown both from saphenous vein (17." | 1.29 | Inhibition of human vascular smooth muscle cell proliferation by the novel multiple-action antihypertensive agent carvedilol. ( Betteridge, LJ; Chan, P; Patel, MK; Schachter, M; Sever, PS, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saeidnia, S | 1 |
| Abdollahi, M | 1 |
| Ahmed, Z | 1 |
| Bajwa, A | 1 |
| Bhardwaj, B | 1 |
| Laster, SB | 1 |
| Magalski, A | 1 |
| Patel, MK | 1 |
| Chan, P | 1 |
| Betteridge, LJ | 1 |
| Schachter, M | 1 |
| Sever, PS | 1 |
| Breckenridge, A | 1 |
| Roberts, DH | 1 |
3 reviews available for carvedilol and Vascular Diseases
| Article | Year |
|---|---|
Toxicological and pharmacological concerns on oxidative stress and related diseases.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; B | 2013 |
Spontaneous coronary artery dissection: the management dilemma continues.
Topics: Adenosine; Adult; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Atorvastatin; Carbazol | 2015 |
Antihypertensive treatment in concomitant peripheral vascular disease: current experience and the potential of carvedilol.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Carbazoles; Carvedilol; Extremities; Hemodynam | 1991 |
1 other study available for carvedilol and Vascular Diseases
| Article | Year |
|---|---|
Inhibition of human vascular smooth muscle cell proliferation by the novel multiple-action antihypertensive agent carvedilol.
Topics: Antihypertensive Agents; Calcium Channel Blockers; Carbazoles; Carvedilol; Cell Division; Depression | 1995 |